Clinical Trial Update: A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety of Hydronidone capsules in patients with hepatic fibrosis or liver cirrhosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis B with Hepatic Fibrosis

Drugs mentioned

• Hydronidone (Hydronidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Chronic Hepatitis B With Hepatic Fibrosis | Phase 3 | Status: COMPLETED